the cancer collaborative is a catalyst for change — where disruptive ideas and creative strategy come together to challenge systems, influence policy, and drive real impact for people affected by cancer.
stakeholders across canada have implemented an oncology biosimilars strategy that improves outcomes for patients, is evidenced informed, ensures appropriate quality and safety measures are in place, and facilitates access to innovative cancer treatments